Literature DB >> 9400991

Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.

A Pearson1, J Greenblatt.   

Abstract

The transcriptional activator E2F1 regulates the expression of genes at the G1/S boundary. We have characterized interactions of the E2F1 activation domain with two general transcription factors, the TATA-box binding protein (TBP) and TFIIH. Two distinct binding sites on E2F1 were identified for TBP (amino acids 386-417 and 415-437) each of which supported activation in mammalian cells when expressed as a fusion to a heterologous DNA-binding domain. Neither of these minimal activation domains independently bound TFIIH; rather, the TFIIH binding site of E2F1 overlaps both domains. Loss of TFIIH-binding by E2F1 resulted in a 60-65% reduction in transactivation, suggesting that the E2F1/TFIIH interaction is important, but not essential, for transactivation. The retinoblastoma protein (Rb) binds directly to E2F1 and represses E2F1-mediated transactivation. We have demonstrated that recombinant Rb can compete with TBP and the p62 subunit of TFIIH for binding to immobilized E2F1. A tumorigenic form of Rb deficient in repressing E2F1-mediated transactivation is likewise deficient in displacing TBP from E2F1. We propose that competition between Rb and both TBP and TFIIH for binding to E2F1 is a mechanism by which Rb inhibits transactivation by E2F1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400991     DOI: 10.1038/sj.onc.1201451

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Transcriptional activation by artificial recruitment in mammalian cells.

Authors:  J Nevado; L Gaudreau; M Adam; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1.

Authors:  Stefan Taubert; Chiara Gorrini; Scott R Frank; Tiziana Parisi; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.

Authors:  Mark Bieda; Xiaoqin Xu; Michael A Singer; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2006-04-10       Impact factor: 9.043

5.  A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.

Authors:  Xiaoqin Xu; Mark Bieda; Victor X Jin; Alina Rabinovich; Mathew J Oberley; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

6.  A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.

Authors:  E Veal; M Eisenstein; Z H Tseng; G Gill
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Functional analysis of a promoter variant identified in the CFTR gene in cis of a frameshift mutation.

Authors:  Victoria Viart; Marie Des Georges; Mireille Claustres; Magali Taulan
Journal:  Eur J Hum Genet       Date:  2011-08-17       Impact factor: 4.246

8.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  A novel yeast protein influencing the response of RNA polymerase II to transcriptional activators.

Authors:  A Emili; R Kobayashi; C J Ingles
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

10.  Regulation of E2F1 activity by acetylation.

Authors:  M A Martínez-Balbás; U M Bauer; S J Nielsen; A Brehm; T Kouzarides
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.